A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry Disease

NCT00196716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Fabry Disease

Interventions

BIOLOGICAL: Fabrazyme (agalsidase beta)

Sponsor

Genzyme, a Sanofi Company